$25.5 Million is the total value of DC Funds, LP's 3 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HOWL | WEREWOLF THERAPEUTICS INC | $10,109,000 | -1.6% | 589,102 | 0.0% | 39.69% | -18.7% | |
| VACC | VACCITECH PLCads | $10,108,000 | -6.2% | 642,204 | 0.0% | 39.68% | -22.5% | |
| New | TSCAN THERAPEUTICS INC | $5,254,000 | – | 630,000 | +100.0% | 20.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VACCITECH PLC | 10 | Q3 2023 | 51.2% |
| WEREWOLF THERAPEUTICS INC | 10 | Q3 2023 | 48.8% |
| TSCAN THERAPEUTICS INC | 9 | Q3 2023 | 33.5% |
View DC Funds, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View DC Funds, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.